DEL-DESIRAN

Trademark usage description

oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based t Read More

Classification Information

Class [005]
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification kind code

Class [042]
Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Classification kind code

Class [044]
Medical and veterinary, beauty, agricultural and forestry

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

2344608

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 287 on 29^th Aug 2024	Pre-Assessment Letter Sent
Submitted for opposition 30 on 19^th Aug 2024	Filed
Submitted for opposition 1 on 19^th Aug 2024	Created
Submitted for opposition 31 on 19^th Aug 2024	Formalized

DEL-DESIRAN

Classification Information

Classification kind code

Class [042]Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Classification kind code

Class [044]Medical and veterinary, beauty, agricultural and forestry

Comment text

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Class [044]
Medical and veterinary, beauty, agricultural and forestry